Skip to content
Disclosery

QNRX QUOIN PHARMACEUTICALS LTD

Follow

SPONSORED ADS (ADR), issuer CIK 1671502

7 managers (7 13F filers) reported a position in QNRX shares at 2025-06-30, 2,537 shares in all. 6 filers opened a position and 0 filers sold out during the quarter.

Managers
7
13F filers
7
New
6
Added
0
Reduced
1
Sold out
0
Shares held by filers
2,537

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2025

Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
RHUMBLINE ADVISERS1,242$11.4K<0.01%new13F-HRTimeline
RAYMOND JAMES FINANCIAL INCin group RAYMOND JAMES FINANCIAL INC717$6.62K<0.01%new13F-HRTimelineGroup
GAMMA Investing LLC240$2.21K<0.01%new13F-HRTimeline
MORGAN STANLEYin group MORGAN STANLEY206$1.9K<0.01%new13F-HRTimelineGroup
UBS Group AGin group UBS Group AG130$1.2K<0.01%new13F-HRTimelineGroup
SBI Securities Co., Ltd.2$18<0.01%-10613F-HRTimeline
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$0new13F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.

Events

  • Ikarian Capital, LLC and 1 other reporting person reported 211,538 QNRX shares, 4.4% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-07. 0001778253-26-000004

    Accepted , ingested